Advanced search
Publication Cover
Current Medical Research and Opinion Volume 17, 2001 - Issue 4
Submit an article Journal homepage
30
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Pure Antiestrogens and Breast Cancer

Abd Elrafea Elkak The Breast Cancer Centre, St George's Hospital and Medical School, Blackshaw Road, London SW17 0QT, UK
&
Kefah Mokbel The Breast Cancer Centre, St George's Hospital and Medical School, Blackshaw Road, London SW17 0QT, UKCorrespondence[email protected]
Pages 282-289 | Published online: 26 Aug 2008

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kefah Mokbel. (2003) Recent advances in breast cancer: the 27th ESMO Congress 2002. Current Medical Research and Opinion 19:2, pages 141-142.
Read now
K. Mokbel & G. Singh-Ranger. (2002) Breast Cancer Chemoprevention-An Update. Current Medical Research and Opinion 18:6, pages 329-331.
Read now

Articles from other publishers (14)

Agnidipta Das, Kanamarlapudi Joshna Lavanya, Nandini, Kamalpreet Kaur & Vikas Jaitak. (2023) Effectiveness of Selective Estrogen Receptor Modulators in Breast Cancer Therapy: An Update. Current Medicinal Chemistry 30:29, pages 3287-3314.
Crossref
Vishal Chandra, Jong Joo Kim, Doris Mangiaracina Benbrook, Anila Dwivedi & Rajani Rai. (2016) Therapeutic options for management of endometrial hyperplasia. Journal of Gynecologic Oncology 27:1.
Crossref
Miroslava Bilecová-Rabajdová, Anna Birková, Peter Urban, Kristína Gregová, Eva Ďurovcová & Mária Mareková. (2013) Naturally Occurring Substances and Their Role in Chemo-protective Effects. Central European Journal of Public Health 21:4, pages 213-219.
Crossref
Noemi Baranda-Avila, C. Adriana Mendoza-Rodr?guez, Sumiko Morimoto, Ignacio Camacho-Arroyo, Christian Guerra-Araiza, Elizabeth Langley & Marco Cerb?n. (2013) Agonistic activity of ICI 182 780 on activation of GSK 3?/AKT pathway in the rat uterus during the estrous cycle. Steroids 78:7, pages 717-725.
Crossref
Norasate Samarnthai, Richard Elledge, Thomas J. Prihoda, Jian Huang, Suleiman Massarweh & I-Tien Yeh. (2012) Pathologic Changes in Breast Cancer After Anti-Estrogen Therapy. The Breast Journal 18:4, pages 362-366.
Crossref
Yoshiya Horimoto, Johan Hartman, Julie Millour, Steven Pollock, Yolanda Olmos, Ka-Kei Ho, R. Charles Coombes, Matti Poutanen, Sari I. Mäkelä, Mona El-Bahrawy, Valerie Speirs & Eric W.-F. Lam. (2011) ERβ1 Represses FOXM1 Expression through Targeting ERα to Control Cell Proliferation in Breast Cancer. The American Journal of Pathology 179:3, pages 1148-1156.
Crossref
Jie Chen, Ana R. Gomes, Lara J. Monteiro, San Yu Wong, Lai Han Wu, Ting-Ting Ng, Christina T. Karadedou, Julie Millour, Ying-Chi Ip, Yuen Nei Cheung, Andrew Sunters, Kelvin Y. K. Chan, Eric W.-F. Lam & Ui-Soon Khoo. (2010) Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer. PLoS ONE 5:8, pages e12293.
Crossref
J Millour, D Constantinidou, A V Stavropoulou, M S C Wilson, S S Myatt, J M-M Kwok, K Sivanandan, R C Coombes, R H Medema, J Hartman, A E Lykkesfeldt & E W-F Lam. (2010) FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene 29:20, pages 2983-2995.
Crossref
T.F.H. Bovee, L.A.P. Hoogenboom & B.M. Thomson. 2009. Endocrine-Disrupting Chemicals in Food. Endocrine-Disrupting Chemicals in Food 259 290 .
Gerrit H. Veeneman. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets 65 126 .
Toine F. H. Bovee, Willem G. E. J. Schoonen, Astrid R. M. Hamers, Marta Jorge Bento & Ad A. C. M. Peijnenburg. (2008) Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities. Analytical and Bioanalytical Chemistry 390:4, pages 1111-1119.
Crossref
Christina Westmose Yde, Mads Gyrd-Hansen, Anne E. Lykkesfeldt, Olaf-Georg Issinger & Jan Stenvang. (2007) Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death. Molecular Cancer Therapeutics 6:6, pages 1869-1876.
Crossref
Jay W. WrightRichard L. StoufferKarin D. Rodland. (2005) High-Dose Estrogen and Clinical Selective Estrogen Receptor Modulators Induce Growth Arrest, p21, and p53 in Primate Ovarian Surface Epithelial Cells. The Journal of Clinical Endocrinology & Metabolism 90:6, pages 3688-3695.
Crossref
Bhuvaneswari Ramaswamy & Charles L Shapiro. (2003) Osteopenia and osteoporosis in women with breast cancer. Seminars in Oncology 30:6, pages 763-775.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.